Preclinical Evaluation of ⁶⁸Ga-labeled RGD Peptide for Detection of Malignant Angiogenesis

Introduction. The early detection of tumor growth remains one of the most important tasks of diagnostic nuclear medicine. The vascular growth being created malignant neoplasms is a good target for the purpose. The molecular participants in the process are gallium-68 labeled vector to the delivery of...

Descrizione completa

Dettagli Bibliografici

Autori principali:	O. E. Klementyeva, A. B. Bruskin, A. S. Lunev, M. G. Rakhimov, K. A. Luneva, G E. Codina
Natura:	Artigo
Lingua:	Russo
Pubblicazione:	LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2020-08-01
Serie:	Разработка и регистрация лекарственных средств
Soggetti:	pet diagnostics tumor angiogenesis gallium-68 «vascular, <sup>68</sup>ga» xenograft rgd
Accesso online:	https://www.pharmjournal.ru/jour/article/view/833
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!